School of Medicine
Showing 301-400 of 1,144 Results
-
Katie Fracalanza
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Fracalanza is interested in factors underlying the development and maintenance of mood and anxiety disorders. She has conducted research on cognitive factors thought to maintain anxiety, such as intolerance of uncertainty and perfectionism. She is interested in the patient perspective, and conducting research from a qualitative lens to better understand this.
-
George Mark Freeman MD PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. Freeman serves as the Site Director for Stanford Psychiatry Residency Training at VA Palo Alto Hospital. His interests include caring for patients with complex mental health conditions, providing medical education to Stanford trainees, and remaining up to date on the latest in neuroscience advances.
EDUCATION
B.S. Biology (Neuroscience), Duke University
M.D. Medical Scientist Training Program, Washington University in St Louis
Ph.D. In Biological and Biomedical Sciences (Neuroscience), Washington University in St Louis
RESIDENCY TRAINING
Psychiatry Residency (Research Track), Stanford University School of Medicine, Stanford, CA
LICENSURE AND CERTIFICATION
Diplomate, General Psychiatry, American Board of Psychiatry and Neurology
Physician and Surgeon Medical License, California
SELECTED SCHOLARSHIPS AND HONORS
National Institute of Mental Health (NIMH) Outstanding Resident Award
James L. O’Leary Prize for Research in Neuroscience Finalist
Ruth L Kirschstein National Research Service Award
United States Fulbright Scholar -
Heather Freeman
Clinical Instructor, Psychiatry and Behavioral Sciences
BioHeather Freeman, PsyD, RYT 500, received her PsyD in Clinical Psychology from Pacific University in 2019. She obtained her 200-hour yoga teaching certification at the Asheville Yoga Center in Asheville, NC in 2014, and her 300-hour yoga teaching certification at the DAYA Foundation in Portland, OR. She previously earned a Master's in Counseling Psychology from Loyola University in Baltimore, MD and is currently working towards becoming a licensed psychologist.
Dr. Freeman continues to align her professional interest in psychology with the ancient wisdom and teachings of yoga. She considers herself a gestalt therapist, and views each person as inherently adaptable, resilient and existing within a variety of intertwined contexts. She combines yoga psychology with Gestalt therapy to create a holistic view of the person that draws on and connects mind, body, and spirit. Yoga, like Gestalt, encourages experiential learning in the here-and-now moment to develop and strengthen awareness and innate resources. Her clinical work has involved working with children in a psychiatry hospital, adolescents and college aged students in college counseling centers, as well as working within primary care and community mental health clinics. She has taught yoga to many different populations including graduate students, adults and children receiving mental health services, older adults with chronic health diagnoses, adults in custody and police officers.
Dr. Freeman’s research has specifically targeted identifying the perception of yoga and illuminating the diverse use of yoga philosophy as an entire system. Her dissertation is a program evaluation on the effects of a yoga teacher training program in a prison, evaluating the effects of training adults in custody to build a personal yoga practice and how to teach yoga to other adults in custody. She is passionate about expanding yoga's accessibility through program development, research and clinical work. -
Becky Fullmer
Administrative Associate 3, Psych/Public Mental Health & Population Sciences
Current Role at StanfordBecky provides administrative support to Dr. Carolyn Rodriguez and the Rodriguez Lab within the School of Medicine's Psychiatry and Behavioral Sciences Department.
-
Lawrence Fung MD PhD
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsDr. Lawrence Fung an assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. He is the director of the Stanford Neurodiversity Project, director of the Neurodiversity Clinic, and principal investigator at the Fung Lab. His work, which focuses on autism and neurodiversity, traverses from multi-modal neuroimaging studies to new conceptualization of neurodiversity and its application to clinical, education, and employment settings. His lab advances the understanding of neural bases of human socio-communicative and cognitive functions by using novel neuroimaging and bioanalytical technologies. Using community-based participatory research approach, his team devises and implements novel interventions to improve the lives of neurodiverse individuals by maximizing their potential and productivity. His work has been supported by various agencies including the National Institutes of Health, Autism Speaks, California Department of Developmental Services, California Department of Rehabilitation, as well as philanthropy. He received his PhD in chemical engineering from Cornell University, and MD from George Washington University. He completed his general psychiatry residency, child and adolescent psychiatry fellowship, and postdoctoral research fellowship at Stanford.
-
Ansgar Furst
Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psych/Public Mental Health & Population SciencesBioDr. Furst is a Clinical Associate Professor (affiliated) of Psychiatry and Behavioral Sciences and of Neurology and Neurological Sciences at Stanford University School of Medicine. He is a Principal Investigator and Director of the California War Related Illness and Injury Study Center (WRIISC) Advanced Fellowship Post-Doctoral program and Associate Director of Neuroimaging. He is also a Senior Research Scientist at the Polytrauma System of Care (PSC) at VA Palo Alto Health Care System. Dr. Furst serves as Associate Editor for the journal Frontiers in Neurology and is a member of the editorial board of NEUROLOGY. His research focuses on chronic multisymptom illness, traumatic brain injury, sleep, pain and neurodegenerative diseases.
For more information please visit:
https://med.stanford.edu/furstlab.html
Member of:
Center for Sleep and Circadian Sciences
https://med.stanford.edu/cscs.html
Faculty Affiliate:
Wu Tsai Human Performance Alliance
https://humanperformance.stanford.edu -
Yuanyuan Gao (She/Her)
Postdoctoral Scholar, Psychiatry
BioYuanyuan Gao completed her PhD at Rensselaer Polytechnic Institute. Her PhD thesis researched the effects of neuromodulation on human motor learning using functional near-infrared spectroscopy (fNIRS). She finished her first postdoctoral training term in Dr. David Boas' lab in Boston University on advanced fNIRS data analysis. She is now a postdoctoral fellow working at Stanford University for her second term of postdoctoral training on the clinical applications of fNIRS. Her research interests are fNIRS, its multimodels with fMRI, EEG, eye-tracker, physiology measurements, neuromodulation and machine learning models, and its applications in clinical research.
-
Joseph Garner
Professor of Comparative Medicine and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe medical research community has long recognized that "good well-being is good science". The lab uses an integrated interdisciplinary approach to explore this interface, while providing tangible deliverables for the well-being of human patients and research animals.
-
Grace Gengoux
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Grace Gengoux is Director of the Autism Intervention Clinic and leads an autism intervention research program focused on developing and evaluating promising behavioral and developmental treatments for Autism Spectrum Disorder (ASD).
Dr. Gengoux is also Associate Chair for Faculty Engagement & Well-being and Department Well-being Director in the Department of Psychiatry and Behavioral Sciences, leading the department's Standing Well-being Advisory Committee. -
William Giardino
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsThe Giardino Laboratory: our group aims to decipher the neural mechanisms underlying psychiatric conditions of stress, addiction, and sleep disturbances. Our work uses combinatorial technologies for precisely mapping, monitoring, and manipulating neural circuits that drive hedonic and homeostatic states. Projects in the lab are funded by the National Institutes of Health (NIAAA), the Whitehall Foundation, and the Brain Research Foundation.
-
Erin Gibson
Assistant Professor of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsGlia make up more than half of the cells in the human brain, but we are just beginning to understand the complex and multifactorial role glia play in health and disease. Glia are decidedly dynamic in form and function. Understanding the mechanisms underlying this dynamic nature of glia is imperative to developing novel therapeutic strategies for diseases of the nervous system that involve aberrant gliogenesis, especially related to changes in myelination.
-
Giancarlo Glick
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioInterested in psychedelic research, ketamine, and psychedelic-assisted therapies. I help organize Stanford Psychedelic Science Group and teach an "Introduction to Psychedelic Medicine" course at the university. Working on clinical trials of MDMA, psilocybin, and 5-meo-DMT.
-
Ira D Glick
Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsSchizophrenia is one of the major public health problems in American medicine. Treatment is partially efficacious but unsatisfactory. Accordingly, our research focuses on treatment outcome in two areas; finding more effective medications which have less side effects than current medications, and in the effects of combining medication with psychosocial interventions.
-
Andrea Goldstein-Piekarski
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)
BioDr. Goldstein-Piekarski directs the Computational Psychiatry, Neuroscience, and Sleep Laboratory (CoPsyN Sleep Lab) as an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and PI within the Sierra-Pacific Mental Illness Research, Education and Clinical Center (MIRECC) at the Palo Alto VA. She received her PhD in 2014 at the University of California, Berkeley where she studied the consequences of sleep on emotional brain function. She then completed a Postdoctoral fellowship at Stanford focusing on understanding the brain basis of anxiety and depression.
As the director of the CoPsyN Sleep Lab she is developing a translational, interdisciplinary research program that combines human neuroimaging, high-density EEG sleep recording, and computational modeling to understand the neural mechanisms through which sleep disruption contributes to affective disorders, particularly depression, across the lifespan. The ultimate goals of this research are to (1) develop mechanistically-informed interventions that directly target aspects of sleep and brain function to prevent and treat affective disorders and (2) identify novel biomarkers which can identify which individuals are most likely to experience improved mood following targeted sleep interventions.
This work is currently supported by The KLS Foundation, a R01 from National Institute of Mental Health, and a R61 from the National Institute of Mental Health. -
Ola Golovinsky
Medical Education Team Manager, Psychiatry and Behavioral Sciences
Current Role at StanfordMedical Education Team Manager, Department of Psychiatry & Behavioral Science
-
Camila Gonzalez
Postdoctoral Scholar, Psychiatry
BioCamila González is a postdoctoral scholar at the Computational Neuroscience Laboratory at Stanford University. Her aim is to develop methods that allow the continual training of deep learning models for neuroimaging applications, suitable for dynamic settings with ongoing data collection. She has received multiple distinctions, including the MICCAI Young Scientist Award and the Best Presentation Award at the EuSoMII annual meeting. Her work was featured in outlets such as the Computer Vision News magazine and the AI-Ready Healthcare podcast. Outside her research, she presided the MICCAI student board for two years and was DEI chair in the first edition of the ContinualAI Unconference.
-
Jessica E. Gonzalez
Soc Science Rsch Prof 3, Psych/Public Mental Health & Population Sciences
BioJessica E. Gonzalez, MSW is the Associate Director for the Mental Health Technology Transfer Center (MHTTC) Network Coordinating Office (NCO). The MHTTC NCO is part of the Center for Dissemination and Implementation (CDI) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Through the MHTTC School Mental Health Initiative, Jessica is coordinating the work of 12 centers that provide training and technical assistance to the mental health and school mental health workforce to increase the use of evidence-based mental health prevention, treatment, and recovery support services for students across the United States.
Jessica has worked in the community as a social worker providing mental health services in school and outpatient clinic settings to children and adolescents of diverse socioeconomic, cultural and ethnic backgrounds. In addition, she has over 10 years of experience in project management and coordination for research and evaluation in the areas of early childhood learning and development, special education, post-secondary education attainment, and delivery of school mental health services. Jessica has also worked for several high school and college programs in the area seeking to improve educational outcomes for first-generation and low-income students of color. -
Cheryl Gore-Felton, Ph.D.
Walter E. Nichols, MD Professor in the School of Medicine
Current Research and Scholarly InterestsMy clinical focus is the treatment of anxiety disorders, including post traumatic stress disorder. My research focuses on developing effective psychotherapy interventions to reduce chronic stress as well as enhance positive health behaviors to reduce morbidity and mortality among patients coping with chronic, medical illnesses which are often life threatening.
-
Heather Gotham
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Gotham’s research focuses on implementation science, including factors affecting implementation, and training and education of health care providers, across a range of evidence-based practices for adolescent and adult substance use and mental health disorders, co-occurring mental health and substance use disorders, and screening, brief intervention, and referral to treatment (SBIRT).
-
Christine E. Gould
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Gould received her Ph.D in psychology from West Virginia University. She completed her internship at VA Palo Alto Health Care System and an Advanced Fellowship in Geriatrics at the GRECC. Dr. Gould is board certified in geropsychology. Her research program develops and tests tailored, self-directed mental health interventions in older adults. Her current funded studies are testing the efficacy of a video-delivered progressive muscle relaxation program with telephone coaching support in reducing anxiety and improving functioning and examining the use of technology by older Veterans. She is also is examining a mobile app-based intervention for depression in middle age and older adults. Dr. Gould has an active interest in training future geriatric mental health clinicians and researchers. She provides mentorship in the following areas: geriatric mental health interventions, technology-delivered interventions for older adults, program evaluation/quality improvement, and qualitative research methods.
-
Carlos Greaves
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioBorn and raised in Caracas, Venezuela. Medical school at the Central University School of Medicine, where Internship was completed.
Residency training at Stanford Medical School, Department of Psychiatry. Work in Community Mental health in Maui, Hawaii for 4 years.
Work at the Veterans Administration in Palo Alto for 3 years. Currently in Private Practice and as consulting psychiatrist at the Vaden Student Health center at Stanford -
Tamar Green
Assistant Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Sciences)
Current Research and Scholarly InterestsThe Brain Imaging, Development, and Genetic (BRIDGE) Lab focuses on disorders associated with child development, such as attention deficits, hyperactivity, and autism spectrum disorders. we aim to uncover biological principles of how genetic variation and its associated downstream pathways affect children's neurodevelopmental disorders.
-
Michael Greicius, MD, MPH
Iqbal Farrukh and Asad Jamal Professor and Professor, by courtesy, of Psychiatry and Behavioral Sciences (Administrative and Academic Special Programs)
Current Research and Scholarly InterestsAs the Medical Director of the Stanford Center for Memory Disorders and Principal Investigator of the Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort, Dr. Greicius' research focuses on elucidating the neurobiologic underpinnings of AD. His lab combines cutting edge brain imaging, "deep" phenotyping, and whole-genome sequencing of human subjects to identify novel pathways involved in AD pathogenesis. The goal of his work is to develop effective treatment for AD patients.
-
Matthew Gunther, MD, MA
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Matthew Gunther graduated with a BA in psychology from the University of Southern California in 2009. Afterwards, he pursued training as a Marriage and Family Therapist, earning a Master of Arts in Clinical Psychology at Pepperdine University in 2011. His career goals shifted from a focus on psychotherapy towards medicine, subsequently graduating from medical school from the University of California, Irvine in 2018. Dr. Gunther completed his general adult psychiatry residency at the University of Southern California/LAC+USC Medical Center in 2022 where he served as Chief Resident for the inpatient service. He subsequently completed his Consultation-Liaison Psychiatry fellowship at Stanford University in 2023.
Dr. Gunther has a passion for teaching and mentorship of medical trainees at all levels. Throughout all stages of training, he was actively involved in admissions, as well as program development. During residency, his particular focus was on curriculum development for inpatient psychiatry, as well as quality improvement projects focused on staff safety and accessibility of psychiatry services for the Los Angeles County population. His work on these areas, in addition to teaching efforts and scholarly work, earned him the Excellence in Residency award for each year of residency training.
Dr. Gunther joined the faculty as a Clinical Assistant Professor of Psychiatry at the Stanford University School of Medicine in July 2023 and currently serves as Assistant Program Director of the Consultation-Liaison Psychiatry Fellowship. His interests in psychiatry include critical care psychiatry, neuropsychiatry, medical education, psychopharmacology in the medically ill, and integrated care. Dr. Gunther works in the Integrated Behavioral Health program where he is Director of Education, with particular focus on resident-based primary care clinics. In addition, he is an attending on the Critical Care and Inpatient Consult-Liaison Psychiatry services. -
Laura Michele Hack
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Laura Hack is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences, Director of Novel & Precision Neurotherapeutics at the Stanford Center for Precision Mental Health and Wellness, Director of the Stanford Translational Precision Mental Health Clinic, and Deputy Director of the Precision Neuromodulation Clinic (PNC) within the VA Palo Alto Health Care System. Dr. Hack's translational research program focuses on identifying bioclinical subtypes of depression and comorbid stress-related disorders and testing mechanistically-guided treatments for these subtypes. Dr. Hack studies treatments spanning repurposed medications, such as pramipexole and guanfacine, neuromodulation techniques, ketamine, MDMA, and psilocybin. Clinically, she specializes in delivering novel treatments, including repetitive transcranial magnetic stimulation (rTMS) and ketamine, to patients suffering from treatment-resistant depression and comorbid stress-related disorders.
-
Scott S. Hall, Ph.D
Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Sciences)
Current Research and Scholarly InterestsMy primary area of scholarly and clinical interest is the pathogenesis of problem behaviors shown by individuals diagnosed with intellectual and developmental disabilities (IDD), particularly those with neurogenetic forms of IDD, such as fragile X syndrome, Cornelia de Lange syndrome and Prader-Willi syndrome. My work aims to both advance understanding of these disorders and to identify effective new treatment approaches for pediatric and adult patient populations by state-of-the-art methodologies, such as brain imaging, eye tracking and functional analysis to determine how environmental and biological factors affect the development of aberrant behaviors in these syndromes. The end goal of my research is to create patient-specific methods for treating the symptoms of these disorders.
-
Haijing Wu Hallenbeck
Instructor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psych/Public Mental Health & Population SciencesBioHaijing Hallenbeck, PhD, is a research investigator at the National Center for PTSD Dissemination & Training Division at VA Palo Alto Health Care System. She is also an Instructor (Affiliated) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She received her PhD in Clinical Psychology from Washington University in St. Louis and completed her predoctoral clinical internship and postdoctoral research fellowship at VA Palo Alto Health Care System. Funded by the VA VISN 21 Early Career Award Program, Dr. Hallenbeck's research focuses on PTSD and depression and their impact on psychosocial functioning. She studies how to leverage digital health technology (e.g., mobile apps) and analytic tools (e.g., machine learning) to provide timely and personalized assessments and interventions for these conditions.
Email: haijing.hallenbeck@stanford.edu -
Joachim Hallmayer
Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsPrincipal Investigator
Infrastructure to facilitate discovery of autism genes
The purpose of this project is to facilitate the discovery of the genes that contribute autism by maintaining an infrastructure which research groups studying the genetics of autism can work collaboratively. This will be
accomplished through workshops, a Virtual Private Network, and access to a database that includes phenotype and genotype data from all participating groups.
Principal Investigator
A California Population-Based Twin Study of Autism
This will address several fundamental questions: (1) What is the heritability of autism (2) What is the contribution of genetic factors to variation in symptom dimensions? (3) Is there a continuum between the quantitative neurocognitive traits and clinical disorder? (4) What proportion of the variance in the neurocognitive traits is accounted for by genetic and non-genetic factors?
Co-Investigator
Center for Integrating Ethics in Genetics Research(Cho)
The goal of this project is to serve as a center of excellence in neurogenetics research, to develop a national model for bench, to bedside research ethics consultation, and to provide training opportunity in biomedical ethics.
Co-Investigator
Gene, Brain and Behavior in Turner Syndrome(Reiss)
The primary objective of this project is to use advanced, multi-modal magnetic resonance imaging (MRI) techniques, analyses of X chromosome parent-of-origin and cognitive-behavioral assessment to elucidate the effects of monosomy and X-linked imprinting on neurodevelopment and neural function in a large cohort of young girls with Turner syndrome, pre-estrogen replacement.
Project Director
Project F: Genomic Analysis in narcolepsy cataplexy
The goal of the project is to locate genes outside the HLA region that influence susceptibility to narcolepsy. In order to localize these genes we will carry out a linkage and association study in the most extensive world-wide collection of DNAs from well-characterized patients with narcolepsy and their families. -
Bonnie Halpern-Felsher
Marron and Mary Elizabeth Kendrick Professor of Pediatrics and Professor, by courtesy, of Epidemiology and Population Health and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsResearch focuses on developmental, cognitive and psychosocial factors involved in adolescents’ and young adults’ health-related decision-making, perceptions of risk and vulnerability, health communication and risk behavior. My research has focused on understanding and reducing health risk behaviors such as tobacco use, alcohol and marijuana use, risky driving, and risky sexual behavior.
-
Mindy Hantke
Public Rel Offcr 2, Psychiatry and Behavioral Sciences
Current Role at StanfordWeb & Communications Administration
-
Antonio Hardan, M.D.
Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe neurobiology of autism
Neuroimaging in individuals with autism
Psychopharmacological treatment of children and adults with autism and/or developmental disorders
The neurobiology and innovative interventions of several neurogenic disorders including DiGeorge Syndrome (Velocardiofacial syndrome; 22q11.2 mutations), PTEN mutations, and Phelan McDermid Syndrome (22q13 mutations). -
Kate Hardy
Clinical Professor, Psychiatry and Behavioral Sciences
BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 15 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. She has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population.
-
Nancy A. Haug
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioNancy A. Haug, PhD is Adjunct Clinical Professor and Addiction Medicine fellowship program faculty in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She currently leads didactics and a journal club for Addiction Medicine fellows, and teaches a postdoctoral seminar on ethics and legal issues for the Clinical Psychology Fellowship Program. Dr. Haug's primary academic affiliation is Professor of Psychology at Palo Alto University, where she teaches, advises and supervises doctoral students in the PGSP-Stanford PsyD Consortium. Dr. Haug previously served as faculty and attending psychologist in the Department of Psychiatry at the University of California San Francisco, and taught in the University of California, Berkeley Alcohol & Drug Studies program. She obtained her PhD in Clinical Psychology and Behavioral Medicine at the University of Maryland, Baltimore County and a Master's degree in Counseling Psychology at Loyola University, Maryland. She completed a clinical internship and postdoctoral fellowship at University of California, San Francisco and San Francisco General Hospital in public service and minority mental health.
Dr. Haug is a member of the American Psychological Association (APA) Ethics Committee and formerly served as a member of the California Psychological Association Ethics Committee. She is a Fellow and Member-at-Large for Practice in the Society of Addiction Psychology (APA, Division 50). Dr. Haug is on the editorial board of the Journal of Psychoactive Drugs and the Journal of Addictive Diseases. She was funded by SAMHSA for a practitioner-education initiative to expand training for evidence-based addiction treatment. Dr. Haug leads the Harm Reduction and Addiction Treatment Laboratory at PAU with current research studies on the implementation of evidence-based practices in addiction treatment, harm reduction for substance use, cannabis vaping and psychedelic-assisted psychotherapy.
Dr. Haug has been licensed as a psychologist in California since 2004, is board certified in addiction psychology by American Board of Professional Psychology, and has an independent practice in Los Gatos, CA. She has clinical expertise in treating substance misuse and eating disorders using motivational interviewing, cognitive-behavioral and mindfulness-based therapies including Acceptance and Commitment Therapy. Dr. Haug is a Stanford WellConnect referral for fellows, residents and faculty in her clinical practice. She recently completed the Stanford YogaX 200-Hour Yoga Teacher Training Program with healthcare setting emphasis. -
Alesha Heath
Basic Life Res Scientist, Psych/Public Mental Health & Population Sciences
BioDr. Alesha Heath is a Postdoctoral Scholar at Psychiatry and Behavioral Sciences at Stanford School of Medicine and the MIRECC the VA Palo Alto. She earned her PhD from the University of Western Australia and Sorbonne University.
Dr. Heath's research has been primarily focused on the mechanisms and applications of brain stimulation therapies, in particular repetitive transcranial magnetic stimulation. Her research involves both basic and clinical components with the aim of improving the efficacy of these therapies for the treatment of disorders such as depression and Alzheimer's disease. -
Katherine (Heflin) Hefcart
Affiliate, Department Funds
Resident in Psychiatry and Behavioral SciencesBioAdult Psychiatry PGY1, focuses on Community/Public advocacy and reproductive mental health. Attended Stanford undergraduate ('11), Harvard T.H. Chan School of Public Health ('15), Dartmouth Geisel Medical School ('23).
-
John P. Hegarty II
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioI am a neuroscientist and Principal Investigator of the Stanford Clinical Neuroscience (CNS) Lab in the Department of Psychiatry and Behavioral Sciences as well as Director of Neuroimaging for the Autism and Developmental Disorders Research Program at Stanford. My innovative research studies clinical aspects of cognitive and behavioral neuroscience, with a special focus on examining the neural circuitry associated with important brain-behavior relationships that may underlie different psychological and psychiatric domains in autistic children, adolescents, and adults. The ultimate goal of this research is to improve our understanding of the development of different cognitive and behavioral skills in order to develop mechanistically driven interventions that will improve precision medicine for mental health. Biologically based diagnosis and treatment are extremely limited for most psychological and psychiatric conditions but also critically needed to increase early identification and improve treatment outcomes, especially for neurodevelopmental disorders in which early intervention is the most beneficial. My early career research has primarily focused on clinical neuroscience using neuroimaging (e.g., MRI & EEG) to examine the effects of different drugs and behavioral interventions on the brain, especially for developing biomarkers for improving treatment planning and monitoring biological changes in response to single dose and clinical trials.
My primary contributions to science thus far fall within these major categories: 1) identifying the neural correlates of individual differences in cognition and behavior, 2) developing new interventions and investigating the neurobiological substrates of response to treatment, 3) examining different factors that contribute to brain development, 4) summarizing and increasing accessibility to autism-related research, and 5) methods development for neuroimaging studies. My earliest research investigated the neurobiology of alexithymia, dyslexia, and stress using structural and functional magnetic resonance imaging to test theories of the mechanisms that contribute to differences in cognition and behavior. My subsequent dissertation research, in which I began to focus on neurodevelopmental disorders, examined the neural correlates of response to beta-blockers in autistic adults and also assessed the contribution of cerebellar circuits to the autism phenotype. During my postdoctoral training, I have developed further skills for working with children in multiple clinical research settings, especially for using advanced neuroimaging approaches to examine important brain-behavior relationships. This includes a recent K99/R00 from the National Institute of Child Health and Human Development (NCT04278898 & NCT05664789) that will assess the neurobiology of restricted and repetitive behaviors in autistic children and examine the efficacy and target engagement of a novel nutritional supplement and investigational drug, N-acetylcysteine (NAC), in the brain. You can find more information about our NAC studies at https://redcap.link/NACandAutism. -
Kimberly Hill
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Hill received her Ph.D. in Clinical Psychology from Ohio University. She completed her doctoral internship at the Veterans Affairs Palo Alto Health Care System and postdoctoral fellowship in the Psychiatry Department at the Stanford University School of Medicine where she currently serves as a Clinical Professor. Dr. Hill has published articles and made presentations related to psychology training, pain management, serious mental illness including Post Traumatic Stress Disorder, and sexual dysfunction.
Dr. Hill's time is divided across clinical, research, administrative, and teaching domains. Her current clinical interests are varied including anxiety, mood disorders, relationship difficulties, and post-traumatic stress disorder. The bulk of her time is committed to psychology training as the Director of Clinical Training for the PGSP-Stanford Psy.D. Consortium. On a national level, she currently serves as the Vice Chair of the Association of Psychology Postdoctoral and Internship Centers (APPIC).
